Fundz

XBiotech Appoints Jan-Paul Simard as Co-Chief Executive Officer

PUBLIC · XBITOct 23, 2026

Position

Chief Executive Officer

Company

XBiotech

Sushma Shivaswamy
AustinManufacturingBiotechnologyHealth CareTherapeutics

Description

XBiotech Inc. has elected Jan-Paul Simard to serve as Co-Chief Executive Officer alongside CEO Dr. Sushma Shivaswamy, effective October 23, 2026

Quick answer

XBiotech Appoints Jan-Paul Simard as Co-Chief Executive Officer (October 23, 2026). XBiotech is based in Austin, Texas, United States.

What did XBiotech announce on October 23, 2026?
XBiotech Inc. has elected Jan-Paul Simard to serve as Co-Chief Executive Officer alongside CEO Dr. Sushma Shivaswamy, effective October 23, 2026
What does XBiotech do?
XBiotech is pioneering the discovery and development of therapeutics based on its True Human™ antibody technology.
Where is XBiotech based?
XBiotech is based in Austin, Texas, United States.
Which similar companies made leadership changes around the same time?
Gyre Therapeutics (October 22, 2026), AbbVie Inc. (November 2, 2026), Jazz Pharmaceuticals plc (October 9, 2026) and Cerenome, Inc. (November 10, 2026) also announced leadership changes within 45 days of XBiotech.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at XBiotech, and when

A new leader at XBiotech brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day XBiotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at XBiotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at XBiotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

XBiotech

Location

5217 Winnebago Lane

Austin, Texas, United States

About

XBiotech is pioneering the discovery and development of therapeutics based on its True Human™ antibody technology. The Company has several candidate products including Natrunix, which are cloned from individual donors who possess natural immunity against certain diseases. XBiotech is focused on advancing healthcare through innovative research and clinical studies. The company is well-equipped with GMP manufacturing facilities and research laboratories.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment XBiotech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ashley
Likely contact at this company
••••••••@••••••••

See Ashley's verified email →

Angela
Likely contact at this company
••••••••@••••••••

See Angela's verified email →

Wenyi
Likely contact at this company
••••••••@••••••••

See Wenyi's verified email →

Janelle
Likely contact at this company
••••••••@••••••••

See Janelle's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for XBiotech's next move

Learn about Strategic plan

XBiotech changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.